Stillbirths occur at a higher rate in the U.S. than previously reported, according to a new study led by researchers at Harvard T.H. Chan School of Public Health… read more.
United Therapeutics Corporation announced two presentations at the upcoming CHEST 2025 Annual Meeting hosted by the American College of Chest Physicians taking place October 19-22, 2025, in Chicago. In… read more.
Only 1 in 7 online stock photo images of blood pressure monitoring correctly show how blood pressure should be measured, contributing to potentially inaccurate readings at home and… read more.
A new treatment has been shown to significantly lower blood pressure in people whose levels stay dangerously high, despite taking several existing medicines, according to the results of… read more.
Researchers report that few people in the USA use salt substitutes to help control high blood pressure despite the fact they are a simple and effective method to… read more.
In endometriosis, cells similar to uterine tissue grow outside the uterus. According to researchers in the Penn State Department of Kinesiology who study the disease, endometriosis is often treated as… read more.
Researchers report that spironolactone, a medication for high blood pressure and heart failure, does not reduce the risk of heart-related death or hospitalization among patients with kidney failure… read more.
Researchers have found why common cuff-based blood pressure readings are inaccurate and how they might be improved, which could improve health outcomes for patients. High blood pressure, or… read more.
Researchers have shown, for the first time, that speckle contrast optical spectroscopy (SCOS) can be used for cuff-less blood pressure monitoring. The new technology could improve early detection… read more.
Liquidia Corporation announced that the FDA has approved Yutrepia (treprostinil) inhalation powder, a prostacyclin analog for adults with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial… read more.
Idorsia announced that the FDA after having released Tryvio (aprocitentan) from its REMS (Risk Evaluation and Mitigation Strategy) requirement (announced on March 17, 2025), has now approved the… read more.
When Emily Rosenfeld was doing a fellowship in maternal-fetal medicine at Rutgers Robert Wood Johnson Medical School (RWJMS), she noticed that many patients were returning to the hospital for hypertension…. read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
